Life Sciences Law360
| May 3, 2012
| William Asher
View "Q&A With Choate's Bill Asher"
William Asher was profiled in Life Sciences Law360 for a featured Q&A session, which focuses in on Mr. Asher’s practice and his take on key industry issues. Mr. Asher discusses topics including the challenges that early-stage biotech companies face during the IPO process, as well as the potential positive effects of the recently enacted JOBS Act.
Thank you for reaching out to contact Choate. Before you send your message, we wanted to make sure you are aware of the following. Please do not send any confidential information in response to this link. Sending an e-mail to Choate does not give rise to an attorney-client relationship, and will not be deemed to disqualify Choate from undertaking any engagement for a current or future client. Before any attorney-client engagement may be formed, Choate will need to check for possible conflicts of interest, you will need to consider whether you wish to retain Choate as counsel, and we will need to consider whether we wish to accept the potential engagement. In the meantime, Choate reserves the right to represent parties with interests adverse to you.